Due to recent voluntary recalls of non-sterile alcohol prep pads (APP), the Association for Professionals in Infection Control and Epidemiology (APIC) is providing important talking points regarding considerations for the use of sterile versus non-sterile APP and actions to take to keep patients safe from infection.
 APIC is closely following the investigation by the Food and Drug Administration (FDA). It will advise its membership on any resulting FDA and/or Centers for Disease Control and Prevention (CDC) guidance regarding the use of sterile versus non-sterile APP in healthcare.
 APIC recommends that its members work closely with product recall coordinators within their institutions to assure a mechanism is in place for obtaining up-to-date information surrounding product recalls, and work with their facilities to ensure immediate notification of any recalled products.
 Infection preventionists play an important role in patient safety. Work with your facility to make sure that recalled products are removed and properly disposed from all points of use within your facility or ancillary areas (including outpatient sites, clinics, storage areas, etc.). Communicate with all care providers about the importance of systematically implementing and enforcing product recalls.
 Follow your internal facility protocols for outbreak investigations related to products.
 Do not assume that all alcohol prep pads are sterile. If you do not see the word sterile anywhere on the packaging, assume that it is not sterile. You may also check with your distributor or manufacturer to confirm the sterility. Of note, the name of the manufacturer is not always on the packaging as it may often only include the name of the distributor.
 Quarantine and sequester the APP as soon as possible, store in a safe location in the facility, remove the APP from all kits within the facility, note all the lot numbers, and report the issue to your local health department and to the FDA. The FDA MedWatch program provides the required forms and process for reporting. Another department within your institution may be assigned this responsibility.
There have been numerous recalls of alcohol prep products in 2011. Check
www.fda.gov/safety to learn more and stay informed.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.